The Diuretic Comparison Project (DCP): For hypertensive patients already on hydrochlorothiazide, switching to chlorthalidone does not improve outcomes
Key Points: Thiazide type diuretics are first-line medications for hypertension (HTN); while…
Does Loop Diuretic Type Affect Clinical Outcomes in Heart Failure? Furosemide vs. Torsemide Compared in the TRANSFORM-HF Trial
Key points: Loop diuretics are routinely used to manage congestion in heart…
UNIVERSAL: Routine ultrasound guidance of femoral vascular access did not reduce bleeding or vascular complications but did facilitate access
Key Points: Femoral access is used for 30% of all coronary procedures,…
Periprocedural loading dose of Atorvastatin reduces MACE in patients with ACS undergoing PCI: Is this a Pleiotropic effect?
A study by Lopes and his colleagues published in JAMA Cardiology has…
SCAI Consensus Statement for Length of Stay after PCI
Dr. Arnold Seto, Dr. Dean Boudoulas and Dr. C. Michael Gibson Discuss
Practical Considerations for Intermediate Risk Patients in TAVR
Dr. Hermiller, Dr. Forrest, and Dr. Gibson Discuss
Innovations from Female Physicians in Pediatric Cardiology
Dr. Kreutzer and Dr. C. Michael Gibson Discuss
SCAI Transition for Value Initiative and Transradial Access
Dr. Adir Shroff and Dr. C. Michael Gibson Discuss
SCAI Peripheral Vascular Disease Device Selection
Dr. Dmitriy Feldman and Dr. C. Michael Gibson Discuss
SCAI PAD Toolkit for Interventional Cardiologists and Primary Care Physicians
Dr. Rajesh Swaminathan, Dr. Dmitriy Feldman and Dr. C. Michael Gibson Discuss
TAVR in Bicuspid Valve Patients
Dr. Chad Kliger, Dr. Sammy Elmariah and Dr. C. Michael Gibson Discuss
Founders Lecture: A 40-year Journey in Evidence Based Medicine
Dr. Roxana Mehran and Dr. C. Michael Gibson Discuss